• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨头畸形伴大理石样皮肤、血管瘤和并指(趾)——一种独特的过度生长综合征。

Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome.

作者信息

Clayton-Smith J, Kerr B, Brunner H, Tranebjaerg L, Magee A, Hennekam R C, Mueller R F, Brueton L, Super M, Steen-Johnsen J, Donnai D

机构信息

Regional Genetic Service, St Marys Hospital, Manchester, UK.

出版信息

Clin Dysmorphol. 1997 Oct;6(4):291-302. doi: 10.1097/00019605-199710000-00001.

DOI:10.1097/00019605-199710000-00001
PMID:9354837
Abstract

We describe nine children with a similar pattern of features including macrocephaly and cutis marmorata telangiectatica congenita. All were large at birth and had a distinctive capillary haemangioma involving the philtrum and upper lip. The seven who survived all developed hydrocephalus and had developmental delay. Six developed body asymmetry and three had internal arteriovenous malformations. Syndactyly of the second and third toes and/or the third and fourth fingers or toes was commonly seen. All of the cases were sporadic. This condition is easily recognizable and should be considered in the differential diagnosis of patients presenting with overgrowth and macrocephaly.

摘要

我们描述了9名具有相似特征模式的儿童,包括巨头畸形和先天性毛细血管扩张性大理石样皮肤。所有患儿出生时体型均较大,且在人中及上唇有独特的毛细血管瘤。存活的7名患儿均出现脑积水并伴有发育迟缓。6名患儿出现身体不对称,3名患儿有颅内动静脉畸形。第二和第三趾及/或第三和第四指或趾并指(趾)畸形很常见。所有病例均为散发性。这种情况很容易识别,在对生长过速和巨头畸形的患者进行鉴别诊断时应予以考虑。

相似文献

1
Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome.巨头畸形伴大理石样皮肤、血管瘤和并指(趾)——一种独特的过度生长综合征。
Clin Dysmorphol. 1997 Oct;6(4):291-302. doi: 10.1097/00019605-199710000-00001.
2
The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations.“先天性大理石样皮肤毛细血管扩张性巨头综合征”这一误称:12例新病例报告及支持将名称修订为巨头-毛细血管畸形的依据
Arch Dermatol. 2009 Mar;145(3):287-93. doi: 10.1001/archdermatol.2008.545.
3
[Macrocephaly-cutis marmorata telangiectatica congenita].[先天性大头-大理石样皮肤毛细血管扩张症]
Ann Dermatol Venereol. 2006 Apr;133(4):349-52. doi: 10.1016/s0151-9638(06)70913-9.
4
Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review.巨头畸形-先天性大理石样皮肤毛细血管扩张症:6例新病例报告及文献复习
Am J Med Genet A. 2004 Sep 15;130A(1):45-51. doi: 10.1002/ajmg.a.30235.
5
Macrocephaly-Cutis marmorata telangiectatica congenita without cutis marmorata?巨头畸形 - 先天性毛细血管扩张性大理石样皮肤但无大理石样皮肤?
Am J Med Genet. 2000 Feb 14;90(4):265-9.
6
Macrocephaly-cutis marmorata telangiectatica congenita: seven cases including two with unusual cerebral manifestations.
Am J Med Genet A. 2004 Apr 1;126A(1):99-103. doi: 10.1002/ajmg.a.20551.
7
[Macrocephaly-capillary malformation. A neonatal case].[巨头畸形-毛细血管畸形。1例新生儿病例]
Arch Pediatr. 2012 Sep;19(9):917-20. doi: 10.1016/j.arcped.2012.06.017. Epub 2012 Aug 9.
8
A case of the new overgrowth syndrome--macrocephaly with cutis marmorata, haemangioma and syndactyly.一例新型过度生长综合征——巨头畸形伴大理石样皮肤、血管瘤和并指畸形。
Clin Dysmorphol. 2000 Jul;9(3):209-11. doi: 10.1097/00019605-200009030-00011.
9
Cutis marmorata telangiectatica congenita: report of 18 cases.先天性大理石样皮肤血管扩张症:18例报告。
Br J Dermatol. 2000 Feb;142(2):366-9. doi: 10.1046/j.1365-2133.2000.03311.x.
10
MRI and neurological findings in macrocephaly-cutis marmorata telangiectatica congenita syndrome: report of ten cases and review of the literature.先天性大头-大理石样皮肤毛细血管扩张综合征的MRI及神经学表现:10例报告并文献复习
Genet Couns. 2005;16(2):117-28.

引用本文的文献

1
Autism Spectrum Disorder in a Child with Megalencephaly-capillary Malformation-polymicrogyria Syndrome: A Case Report.巨脑回-毛细血管畸形-多小脑回综合征患儿的自闭症谱系障碍:一例报告
Clin Psychopharmacol Neurosci. 2025 Aug 31;23(3):516-519. doi: 10.9758/cpn.24.1233. Epub 2025 Jan 17.
2
Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP): A Rare Dynamic Genetic Disorder.巨脑回-毛细血管畸形-多小脑回综合征(MCAP):一种罕见的动态遗传性疾病。
Cureus. 2022 May 18;14(5):e25123. doi: 10.7759/cureus.25123. eCollection 2022 May.
3
Brain overgrowth associated with megalencephaly-capillary malformation syndrome causing progressive Chiari and syringomyelia.
与巨头畸形-毛细血管畸形综合征相关的脑过度生长导致进行性Chiari畸形和脊髓空洞症。
Surg Neurol Int. 2022 May 20;13:211. doi: 10.25259/SNI_1016_2021. eCollection 2022.
4
Diagnostic Approach to Macrocephaly in Children.儿童巨头症的诊断方法
Front Pediatr. 2022 Jan 14;9:794069. doi: 10.3389/fped.2021.794069. eCollection 2021.
5
Autism spectrum disorder in a child with megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP).患有巨脑-毛细血管畸形-多小脑回畸形综合征的儿童的自闭症谱系障碍。
BMJ Case Rep. 2021 Dec 30;14(12):e247034. doi: 10.1136/bcr-2021-247034.
6
Megalencephaly-capillary malformation syndrome and associated hydrocephalus: treatment options and revision of the literature.巨脑-毛细血管畸形综合征伴脑积水:治疗选择及文献复习。
Childs Nerv Syst. 2021 Aug;37(8):2441-2449. doi: 10.1007/s00381-021-05222-8. Epub 2021 May 28.
7
One of the First Cases with PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review.沙特阿拉伯首例与PIK3CA相关过度生长谱系(PROS)病例:病例报告及文献综述
Cureus. 2020 Jan 7;12(1):e6586. doi: 10.7759/cureus.6586.
8
Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CA.巨脑-毛细血管畸形综合征中的生长激素缺乏:与 PIK3CA 激活突变相关。
Am J Med Genet A. 2020 Jan;182(1):162-168. doi: 10.1002/ajmg.a.61403. Epub 2019 Nov 15.
9
Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.PIK3CA 相关过度生长谱和 Proteus 综合征中的血栓形成危险因素。
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):571-581. doi: 10.1002/ajmg.c.31735. Epub 2019 Sep 6.
10
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.节段性过度生长综合征诊断中的临床陷阱:一个携带 PIK3CA 基因 c.2740G > A 突变的患儿。
Ital J Pediatr. 2018 Sep 19;44(1):110. doi: 10.1186/s13052-018-0568-8.